Adverse Events
Group | W/D due to ADEs RR (95% CI) | Headache RR (95% CI) | Nausea RR (95% CI) | Dizziness RR (95% CI) | Somnolence RR (95% CI) | Fatigue RR (95% CI) |
---|---|---|---|---|---|---|
ADEs=adverse drug events; CI=confidence interval; N/A = not available; RR = relative risk; W/D = withdrawal. | ||||||
a P<.05. | ||||||
Dopamine agonists | 1.35 (1.00–1.81)a | 1.20 (0.98–1.47) | 3.25 (2.36–4.48)a | 1.47 (1.02–2.13)a | 1.94 (1.45–2.61)a | 1.37 (1.01–1.86)a |
Pramipexole | 1.15 (0.49–2.69) | 0.99 (0.64–1.54) | 2.68 (1.51–4.76)a | 1.03 (0.51–2.07) | 1.55 (0.75–3.20) | 1.09 (0.64–1.85) |
Ropinirole | 1.49 (1.06–2.10)a | 1.21 (0.95–1.54) | 3.95 (2.76–5.66)a | 1.72 (1.13–2.62)a | 2.03 (1.47–2.80)a | 1.72 (1.18–2.68)a |
Rotigotine | 0.46 (0.08–2.58) | 1.34 (0.54–3.33) | 0.82 (0.16–4.24) | 0.58 (0.19–1.73) | N/A | 0.78 (0.32–1.92) |
Sumanirole | 1.11 (0.06–19.45) | 2.68 (1.01–7.11)a | 4.77 (0.65–34.69) | 4.53 (0.62–33.04) | N/A | N/A |